Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

NCT03616236 is registered in ClinicalTrials.gov with Friends Research Institute, Inc. as lead sponsor.

NCT NCT03616236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03616236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Lead sponsor
Friends Research Institute, Inc.
Phase
Phase 3
Overall status
Suspended
Start date
July 1, 2022
Completion date
December 30, 2026
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use